Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Exogenous Infection
1.2.5 Hematological Diseases
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Treatment Market Perspective (2018-2029)
2.2 Monoclonal Antibody Treatment Growth Trends by Region
2.2.1 Global Monoclonal Antibody Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Monoclonal Antibody Treatment Historic Market Size by Region (2018-2024)
2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Region (2024-2029)
2.3 Monoclonal Antibody Treatment Market Dynamics
2.3.1 Monoclonal Antibody Treatment Industry Trends
2.3.2 Monoclonal Antibody Treatment Market Drivers
2.3.3 Monoclonal Antibody Treatment Market Challenges
2.3.4 Monoclonal Antibody Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Treatment Players by Revenue
3.1.1 Global Top Monoclonal Antibody Treatment Players by Revenue (2018-2024)
3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Treatment Revenue
3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2022
3.5 Monoclonal Antibody Treatment Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Treatment Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Treatment Breakdown Data by Type
4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2018-2024)
4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2024-2029)
5 Monoclonal Antibody Treatment Breakdown Data by Application
5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2018-2024)
5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Monoclonal Antibody Treatment Market Size (2018-2029)
6.2 North America Monoclonal Antibody Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Monoclonal Antibody Treatment Market Size by Country (2018-2024)
6.4 North America Monoclonal Antibody Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size (2018-2029)
7.2 Europe Monoclonal Antibody Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Monoclonal Antibody Treatment Market Size by Country (2018-2024)
7.4 Europe Monoclonal Antibody Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size (2018-2029)
8.2 Asia-Pacific Monoclonal Antibody Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Treatment Market Size (2018-2029)
9.2 Latin America Monoclonal Antibody Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Monoclonal Antibody Treatment Market Size by Country (2018-2024)
9.4 Latin America Monoclonal Antibody Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size (2018-2029)
10.2 Middle East & Africa Monoclonal Antibody Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Treatment Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Monoclonal Antibody Treatment Introduction
11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Monoclonal Antibody Treatment Introduction
11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Treatment Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Treatment Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Treatment Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Treatment Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.8.5 AbbVie Recent Development
11.9 Shanghai Junshi Biosciences Co.,Ltd
11.9.1 Shanghai Junshi Biosciences Co.,Ltd Company Detail
11.9.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview
11.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Introduction
11.9.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development
11.10 Innovent Biologics
11.10.1 Innovent Biologics Company Detail
11.10.2 Innovent Biologics Business Overview
11.10.3 Innovent Biologics Monoclonal Antibody Treatment Introduction
11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.10.5 Innovent Biologics Recent Development
11.11 Jiangsu Hengrui Medicine Co.,Ltd.
11.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
11.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Introduction
11.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.12 BeiGene, Ltd.
11.12.1 BeiGene, Ltd. Company Detail
11.12.2 BeiGene, Ltd. Business Overview
11.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Introduction
11.12.4 BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.12.5 BeiGene, Ltd. Recent Development
11.13 Grand Pharmaceutical (China) Co., Ltd
11.13.1 Grand Pharmaceutical (China) Co., Ltd Company Detail
11.13.2 Grand Pharmaceutical (China) Co., Ltd Business Overview
11.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Introduction
11.13.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Development
11.14 Henlius
11.14.1 Henlius Company Detail
11.14.2 Henlius Business Overview
11.14.3 Henlius Monoclonal Antibody Treatment Introduction
11.14.4 Henlius Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.14.5 Henlius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cancer
Table 3. Key Players of Autoimmune Diseases
Table 4. Key Players of Exogenous Infection
Table 5. Key Players of Hematological Diseases
Table 6. Global Monoclonal Antibody Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Monoclonal Antibody Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Monoclonal Antibody Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Monoclonal Antibody Treatment Market Share by Region (2018-2024)
Table 10. Global Monoclonal Antibody Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Monoclonal Antibody Treatment Market Share by Region (2024-2029)
Table 12. Monoclonal Antibody Treatment Market Trends
Table 13. Monoclonal Antibody Treatment Market Drivers
Table 14. Monoclonal Antibody Treatment Market Challenges
Table 15. Monoclonal Antibody Treatment Market Restraints
Table 16. Global Monoclonal Antibody Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Monoclonal Antibody Treatment Market Share by Players (2018-2024)
Table 18. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
Table 19. Ranking of Global Top Monoclonal Antibody Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Antibody Treatment Product Solution and Service
Table 23. Date of Enter into Monoclonal Antibody Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2018-2024)
Table 31. Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Monoclonal Antibody Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Monoclonal Antibody Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Monoclonal Antibody Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Monoclonal Antibody Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Monoclonal Antibody Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Monoclonal Antibody Treatment Product
Table 51. Pfizer Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Bayer Company Detail
Table 54. Bayer Business Overview
Table 55. Bayer Monoclonal Antibody Treatment Product
Table 56. Bayer Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 57. Bayer Recent Development
Table 58. Sanofi Company Detail
Table 59. Sanofi Business Overview
Table 60. Sanofi Monoclonal Antibody Treatment Product
Table 61. Sanofi Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 62. Sanofi Recent Development
Table 63. Merck Company Detail
Table 64. Merck Business Overview
Table 65. Merck Monoclonal Antibody Treatment Product
Table 66. Merck Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 67. Merck Recent Development
Table 68. GlaxoSmithKline Company Detail
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Monoclonal Antibody Treatment Product
Table 71. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche Monoclonal Antibody Treatment Product
Table 76. Roche Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Novartis Company Detail
Table 79. Novartis Business Overview
Table 80. Novartis Monoclonal Antibody Treatment Product
Table 81. Novartis Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. AbbVie Company Detail
Table 84. AbbVie Business Overview
Table 85. AbbVie Monoclonal Antibody Treatment Product
Table 86. AbbVie Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 87. AbbVie Recent Development
Table 88. Shanghai Junshi Biosciences Co.,Ltd Company Detail
Table 89. Shanghai Junshi Biosciences Co.,Ltd Business Overview
Table 90. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product
Table 91. Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 92. Shanghai Junshi Biosciences Co.,Ltd Recent Development
Table 93. Innovent Biologics Company Detail
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Monoclonal Antibody Treatment Product
Table 96. Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 97. Innovent Biologics Recent Development
Table 98. Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
Table 99. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 100. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product
Table 101. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 102. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
Table 103. BeiGene, Ltd. Company Detail
Table 104. BeiGene, Ltd. Business Overview
Table 105. BeiGene, Ltd. Monoclonal Antibody Treatment Product
Table 106. BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 107. BeiGene, Ltd. Recent Development
Table 108. Grand Pharmaceutical (China) Co., Ltd Company Detail
Table 109. Grand Pharmaceutical (China) Co., Ltd Business Overview
Table 110. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product
Table 111. Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 112. Grand Pharmaceutical (China) Co., Ltd Recent Development
Table 113. Henlius Company Detail
Table 114. Henlius Business Overview
Table 115. Henlius Monoclonal Antibody Treatment Product
Table 116. Henlius Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 117. Henlius Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Treatment Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Monoclonal Antibody Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cancer Features
Figure 4. Autoimmune Diseases Features
Figure 5. Exogenous Infection Features
Figure 6. Hematological Diseases Features
Figure 7. Global Monoclonal Antibody Treatment Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Monoclonal Antibody Treatment Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Monoclonal Antibody Treatment Report Years Considered
Figure 13. Global Monoclonal Antibody Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Monoclonal Antibody Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Monoclonal Antibody Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Monoclonal Antibody Treatment Market Share by Players in 2022
Figure 17. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Treatment Revenue in 2022
Figure 19. North America Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 21. United States Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 25. Germany Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibody Treatment Market Share by Region (2018-2029)
Figure 33. China Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 48. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 49. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 50. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 52. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 53. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 54. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 55. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 56. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 57. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 58. BeiGene, Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 59. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 60. Henlius Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed